Descriptive Analysis of Pediatric Studies Included in the European Union Post-Authorization Study Register from 2010 to 2023

Background/Objectives: This work aimed to analyze pediatric Post-Authorization Studies (PASs) registered in the European Union electronic Register of Post-Authorization Studies (EU PAS Register) from September 2010 to April 2023 to identify trends in terms of timing, age groups, and therapeutic area...

Full description

Saved in:
Bibliographic Details
Main Authors: Annalisa Landi, Giorgio Reggiardo, Antonella Didio, Annunziata D’Ercole, Adriana Ceci, Grace Shalom Govere, Donato Bonifazi, Fedele Bonifazi, Salvatore Crisafulli, Gianluca Trifirò, Florentia Kaguelidou, Katja Marja Hakkarainen, Katarina Gvozdanović, Francesco Barone-Adesi, Andrealuna Ucciero, Mariagrazia Felisi
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Pediatric Reports
Subjects:
Online Access:https://www.mdpi.com/2036-7503/17/1/24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850082406541819904
author Annalisa Landi
Giorgio Reggiardo
Antonella Didio
Annunziata D’Ercole
Adriana Ceci
Grace Shalom Govere
Donato Bonifazi
Fedele Bonifazi
Salvatore Crisafulli
Gianluca Trifirò
Florentia Kaguelidou
Katja Marja Hakkarainen
Katarina Gvozdanović
Francesco Barone-Adesi
Andrealuna Ucciero
Mariagrazia Felisi
author_facet Annalisa Landi
Giorgio Reggiardo
Antonella Didio
Annunziata D’Ercole
Adriana Ceci
Grace Shalom Govere
Donato Bonifazi
Fedele Bonifazi
Salvatore Crisafulli
Gianluca Trifirò
Florentia Kaguelidou
Katja Marja Hakkarainen
Katarina Gvozdanović
Francesco Barone-Adesi
Andrealuna Ucciero
Mariagrazia Felisi
author_sort Annalisa Landi
collection DOAJ
description Background/Objectives: This work aimed to analyze pediatric Post-Authorization Studies (PASs) registered in the European Union electronic Register of Post-Authorization Studies (EU PAS Register) from September 2010 to April 2023 to identify trends in terms of timing, age groups, and therapeutic areas and to discuss pediatric specificities and sources of funding for the PASs. Methods: A screening process identified PASs conducted exclusively on the pediatric population, and instructions were provided to ensure standardized data collection from the EU PAS Register. A univariate linear regression descriptive analysis was performed to assess trends over time, while a multivariate linear regression analysis helped explore additional characteristics of these studies. Results: Of the 2574 PASs extracted from the EU PAS Registry, 165 were included in this analysis. The majority of pediatric PASs were observational studies (86%), and most of them utilized secondary data (53%). The annual number of PASs increased significantly between 2010 and 2023. As envisaged, the largest part was funded by pharmaceutical companies (62%). Anti-infectives for systemic uses (25%), medicines for the nervous system (18%), and antineoplastic and immunomodulating agents (15%) resulted in the most studied drugs. Conclusions: Our findings show that post-marketing observational research in pediatric populations has increased over time. Nevertheless, industry–academia collaboration should be encouraged, and regulatory guidance is needed to prioritize research in areas of unmet therapeutic need.
format Article
id doaj-art-9f6e88463f6948faa9e6e8c75f70a81d
institution DOAJ
issn 2036-7503
language English
publishDate 2025-02-01
publisher MDPI AG
record_format Article
series Pediatric Reports
spelling doaj-art-9f6e88463f6948faa9e6e8c75f70a81d2025-08-20T02:44:32ZengMDPI AGPediatric Reports2036-75032025-02-011712410.3390/pediatric17010024Descriptive Analysis of Pediatric Studies Included in the European Union Post-Authorization Study Register from 2010 to 2023Annalisa Landi0Giorgio Reggiardo1Antonella Didio2Annunziata D’Ercole3Adriana Ceci4Grace Shalom Govere5Donato Bonifazi6Fedele Bonifazi7Salvatore Crisafulli8Gianluca Trifirò9Florentia Kaguelidou10Katja Marja Hakkarainen11Katarina Gvozdanović12Francesco Barone-Adesi13Andrealuna Ucciero14Mariagrazia Felisi15TEDDY European Network of Excellence for Pediatric Research, 27100 Pavia, ItalyTEDDY European Network of Excellence for Pediatric Research, 27100 Pavia, ItalyFondazione per la Ricerca Farmacologica Gianni Benzi Onlus, 70124 Bari, ItalyFondazione per la Ricerca Farmacologica Gianni Benzi Onlus, 70124 Bari, ItalyTEDDY European Network of Excellence for Pediatric Research, 27100 Pavia, ItalyCVBF–Consorzio per Valutazioni Biologiche e Farmacologiche, 70122 Bari, ItalyTEDDY European Network of Excellence for Pediatric Research, 27100 Pavia, ItalyTEDDY European Network of Excellence for Pediatric Research, 27100 Pavia, ItalyDepartment of Diagnostics and Public Health, University of Verona, 37134 Verona, ItalyDepartment of Diagnostics and Public Health, University of Verona, 37134 Verona, ItalyAssistance Publique–Hôpitaux de Paris, Hôpital Universitaire Robert-Debré Centre d’Investigations Cliniques et d’Epidémiologie Clinique, 75019 Paris, FranceParexel International, Epidemiology and Real-World Evidence, 41123 Gothenburg, SwedenPharmacoepidemiology Department, Teaching Institute of Public Health “Dr. Andrija Stampar”, Zagreb 10 000, CroatiaDepartment of Translational Medicine, University of Eastern Piedmont, 28100 Novara, ItalyHospital Pharmacy, University Hospital Maggiore della Carità, 28100 Novara, ItalyTEDDY European Network of Excellence for Pediatric Research, 27100 Pavia, ItalyBackground/Objectives: This work aimed to analyze pediatric Post-Authorization Studies (PASs) registered in the European Union electronic Register of Post-Authorization Studies (EU PAS Register) from September 2010 to April 2023 to identify trends in terms of timing, age groups, and therapeutic areas and to discuss pediatric specificities and sources of funding for the PASs. Methods: A screening process identified PASs conducted exclusively on the pediatric population, and instructions were provided to ensure standardized data collection from the EU PAS Register. A univariate linear regression descriptive analysis was performed to assess trends over time, while a multivariate linear regression analysis helped explore additional characteristics of these studies. Results: Of the 2574 PASs extracted from the EU PAS Registry, 165 were included in this analysis. The majority of pediatric PASs were observational studies (86%), and most of them utilized secondary data (53%). The annual number of PASs increased significantly between 2010 and 2023. As envisaged, the largest part was funded by pharmaceutical companies (62%). Anti-infectives for systemic uses (25%), medicines for the nervous system (18%), and antineoplastic and immunomodulating agents (15%) resulted in the most studied drugs. Conclusions: Our findings show that post-marketing observational research in pediatric populations has increased over time. Nevertheless, industry–academia collaboration should be encouraged, and regulatory guidance is needed to prioritize research in areas of unmet therapeutic need.https://www.mdpi.com/2036-7503/17/1/24Post-Authorization StudiespediatricEU PAS Registerdescriptive analysis
spellingShingle Annalisa Landi
Giorgio Reggiardo
Antonella Didio
Annunziata D’Ercole
Adriana Ceci
Grace Shalom Govere
Donato Bonifazi
Fedele Bonifazi
Salvatore Crisafulli
Gianluca Trifirò
Florentia Kaguelidou
Katja Marja Hakkarainen
Katarina Gvozdanović
Francesco Barone-Adesi
Andrealuna Ucciero
Mariagrazia Felisi
Descriptive Analysis of Pediatric Studies Included in the European Union Post-Authorization Study Register from 2010 to 2023
Pediatric Reports
Post-Authorization Studies
pediatric
EU PAS Register
descriptive analysis
title Descriptive Analysis of Pediatric Studies Included in the European Union Post-Authorization Study Register from 2010 to 2023
title_full Descriptive Analysis of Pediatric Studies Included in the European Union Post-Authorization Study Register from 2010 to 2023
title_fullStr Descriptive Analysis of Pediatric Studies Included in the European Union Post-Authorization Study Register from 2010 to 2023
title_full_unstemmed Descriptive Analysis of Pediatric Studies Included in the European Union Post-Authorization Study Register from 2010 to 2023
title_short Descriptive Analysis of Pediatric Studies Included in the European Union Post-Authorization Study Register from 2010 to 2023
title_sort descriptive analysis of pediatric studies included in the european union post authorization study register from 2010 to 2023
topic Post-Authorization Studies
pediatric
EU PAS Register
descriptive analysis
url https://www.mdpi.com/2036-7503/17/1/24
work_keys_str_mv AT annalisalandi descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT giorgioreggiardo descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT antonelladidio descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT annunziatadercole descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT adrianaceci descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT graceshalomgovere descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT donatobonifazi descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT fedelebonifazi descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT salvatorecrisafulli descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT gianlucatrifiro descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT florentiakaguelidou descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT katjamarjahakkarainen descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT katarinagvozdanovic descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT francescobaroneadesi descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT andrealunaucciero descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023
AT mariagraziafelisi descriptiveanalysisofpediatricstudiesincludedintheeuropeanunionpostauthorizationstudyregisterfrom2010to2023